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Abstract 
It has been shown that angiotensin II and PMA increase the expression of proto-oncogenes (c-fos, c-myc and c-mos) in liver cells. In 
this study the effects of angiotensin II and PMA on c-fos transcription and mRNA stability were investigated. Using nuclear un-off 
transcription assays, it was observed that PMA and angiotensin II induced a rapid increase in c-fos transcription. The transcription rate of 
the GAPDH gene did not change, indicating that the effects were not general on gene transcription. The ability of these agents to 
modulate proto-oncogene mRNA stability was tested by measuring c-fos mRNA half-life. It was observed that c-fos mRNA half-life was 
relatively short (= 14-18 min) and that angiotensin II and PMA markedly stabilized mRNA, increasing its half-life (= 4-fold and 
= 2-fold, respectively). The protein synthesis inhibitor cycloheximide increased mRNA stability to a much greater extent. Our results 
clearly demonstrate hat angiotensin II and PMA increased c-fos mRNA accumulation i liver cells through two actions: induction of 
c-fos gene transcription and increase in mRNA stability. 
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1. Introduction 
It is now becoming clear that, in addition to growth 
factors, many hormones, neurotransmitters and autacoids 
are also able to induce changes at the level of genetic 
expression in very short periods of time [1,2]. The earliest 
known set of genes that respond to growth factors and 
hormones are the so-called immediate arly genes [3-5]. 
These genes are transcriptionally activated (i.e., they are 
under the control of transactivating proteins that bind DNA 
and regulate gene transcription). One of the most interest- 
ing immediate arly genes is c-fos. This proto-oncogene is 
the cellular homolog of v-fos, the bone-transforming gene 
of the FBJ murine osteosarcoma virus [6,7] and its product, 
Fos, is a constituent of the AP1 transcription factor [8]. 
The physiological significance of the rapid induction of 
immediate early genes is not yet clear; however, the 
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mechanisms that mediate such changes in gene expression 
are starting to be delineated [9-11]. 
Angiotensin II is an octapeptide mediator that induces 
rapid responses uch as increasing the production of IP 3 
and the mobilization of intracellular calcium, activation or 
inactivation of regulatory enzymes, contraction, secretion, 
etc., and long-lasting phenomena, such as cell prolifera- 
tion, hypertrophy, differentiation, etc. see Ref. [12] and 
references therein. In liver cells, angiotensin II activates 
phosphorylase a activity via the phosphoinositide 
turnover/calcium mobilization signal transduction path- 
way through AT~ receptors [13,14]; this receptor subtype 
seems also to be coupled in an inhibitory fashion to 
adenylylcyclase in these cells [14]. 
Angiotensin II (through activation of AT l receptors) 
and phorbol 12-myristate 13-acetate (PMA) induce, dose- 
dependently, proto-oncogene mRNA accumulation, in iso- 
lated rat hepatocytes [15]. Serine/threonine and tyrosine 
protein kinases seem to participate in these effects [16]. 
Interestingly, the increases in expression of c-fos induced 
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by these agents are only partially blocked by actinomycin 
D, indicating that not all the effects of the vasopressor 
peptide and the tumor promoter take place at transcrip- 
tional level. We further investigated the processes that 
angiotensin II and PMA modulate to alter the expression 
of c-fos mRNA. Our results clearly indicate that the effects 
of these agents have two important components: increase 
in c-fos transcription and stabilization of mRNA. 
in agarose-formaldehyde gels stained with ethidium bro- 
mide. RNA was quantified by A260 and equal amounts 
were spotted onto Nylon membranes. RNA was cross-lin- 
ked and hybridized with nick-translated probes for c-fos 
and GAPDH genes as described [15,16]. Filters were au- 
toradiographed and the signals were analyzed using a 
DHU Beckman densitometer. 
2. Mater ia l s  and  methods  
Materials. Angiotensin II, phorbol 12-myristate 13- 
acetate (PMA), actinomycin D, cycloheximide, Denhardt's 
solution reagents and Nonidet P-40 were obtained from 
Sigma Chemicals. Agarose was from BioRad. Nylon mem- 
branes, nick translation kits, dCTP (6000 Ci/mmol), UTP 
(3000 Ci/mmol) and the nucleotides used for the run-off 
assays were from Amersham. Restriction enzymes and 
molecular weight standards were from New England Bio- 
labs. 
Cell isolation. Experiments were performed with liver 
cells isolated from female Wistar rats (220-250 g) fed ad 
libitum. Hepatocytes were isolated by the method of Berry 
and Friend [17] and were incubated in Krebs Ringer 
bicarbonate buffer under an atmosphere of 95% 02/5% 
CO 2 (pH 7.4) at 37°C [13,15,16]. 
Nuclear run-off transcription assays. Nuclei were ob- 
tained from freshly isolated hepatocytes treated with the 
agents indicated, essentially as described by Greenberg et 
al. [ 18]. Briefly, 100 mg of hepatocytes were incubated for 
the times indicated with the agents of interest. The cells 
were pelleted and lysed with Nonidet P-40 containing 
buffer [18], nuclei were isolated by rapid centrifugation, 
resuspended in glycerol-containing buffer [18] and frozen 
in liquid nitrogen until their use. For the transcription 
assays, nuclei were thawed and mixed with reaction buffer 
[18] containing 100/xCi of [32p]UTP and incubated for 30 
min at 30°C. The labeled RNA was isolated by the method 
of Chomczynski and Sacchi [19]. DNA binding to nylon 
membranes [18] and RNA hybridization with nylon-fixed 
DNA [4] were performed as described. The plasmids used 
were the c-fos Amprobe from Amersham and the cDNA 
clone of glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) [20]. From these plasmids a615 bp (EcoRI-PstI) 
fragment of c-fos and a 599 bp (Sau 3A) fragment of 
GAPDH were purified; 100 ng of these fragments were 
spotted onto nylon membranes and used for hybridization 
against labeled RNA. No signal was observed in experi- 
ments performed in the absence of nuclei or nucleotides; 
similarly no hybridization was observed when an unrelated 
DNA (Escherichia cold was spotted. 
Half-life mRNA measurements. Hepatocytes were incu- 
bated for the times indicated with the agents of interest. 
Cells were immediately frozen in a dry ice-ethanol bath 
and RNA isolated [t9]. Integrity of total RNA was verified 
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Fig. 1. Analysis of c-fos transcription i isolated nuclei. DNA fragments 
of c-fos proto-oncogene (EcoRI-PstI) and GAPDH (Sau 3A) gene were 
spotted onto nylon membranes and hybridized with 32p-labeled run-off 
transcripts from nuclei isolated at different imes (0-30 min) after the 
addition of buffer (D, I ) ,  0.1 /xM angiotensin II (O, O)  or 1 /zM PMA 
(~, O) to hepatocytes. Radioactivity was visualized by autoradiography 
and quantified by densitometric analysis. Plotted are the means of four 
independent experiments for hybridization using the c-fos gene (solid 
symbols), or the GAPDH cDNA (open symbols). Data are presented in
arbitrary densitometric units (S.E.M. are within the symbols). The inset 
shows a representative film. 
3. Results  and d iscuss ion cific, i.e., possibly affecting other immediate arly genes 
[15]. In addition, control experiments were performed, 
incubating the cells with actinomycin D (5 /zg/ml) for 15 
min before nuclei isolation; under these conditions, the 
rates of transcription of both c-fos and the GAPDH gene 
were essentially abolished (inhibition of 95-99%), clearly 
indicating that this agent was convincingly blocking this 
process. 
As already mentioned, in whole cells, the accumulation 
The effects of angiotensin II and PMA on the rates of 
transcription in isolated nuclei were studied, in order to 
investigate the mechanism(s) involved in the increase in 
c-fos mRNA accumulation induced by these agents. For 
this purpose, cells were incubated in the absence (buffer 
alone) or presence of angiotensin II (100 riM) or PMA (1 
/zM) during the times indicated (the concentrations used 
are near maximally effective for induction of c-fos expres- 
sion in hepatocytes [15]); nuclei were isolated and run-off 
transcription assays were performed. Results are presented 
in Fig. I. 
It can be observed that in cells incubated in the absence 
of any agent the rate of c-fos transcription is similar at 1 
and 5 min of incubation and decreased at later times (Fig. 
1). In contrast, the rate of transcription of the GAPDH 
gene was fairly constant during the times examined (Fig. 
1). The results indicate that c-fos transcription was already 
stimulated and slowly returned toward resting rates. This 
finding is consistent with the observations by Kruijer et al. 
[21], that liver cell isolation is capable of inducing c-fos 
expression. Therefore, our data indicate that our basal 
actually represents a stimulated state due to the cell isola- 
tion procedure and that such stimulus progressively van- 
ishes. 
PMA and angiotensin II markedly stimulated transcrip- 
tion. As early as 1 min after the addition of these agents, 
clear increases, relative to the basal, were observed, and 
such effects were much more marked when the cells were 
incubated for 5 or 15 min with angiotensin II or PMA. At 
30 min of incubation the effects of these agents decreased 
but the rate of c-fi)s transcription was clearly much bigger 
than that observed in cells incubated in the absence of 
these agents (Fig. 1). It should be mentioned that the 
magnitude and the temporal course of the effects of an- 
giotensin II and PMA were not identical. The effect of 
PMA was consistently bigger in magnitude than that of 
angiotensin II and declined more rapidly. In contrast he 
effect of angiotensin II was of smaller magnitude but 
decreased more slowly. This is consistent with the bigger 
efficacy of PMA to increase c-los expression in isolated 
liver cells [15] and may also suggest differences in the 
mechanisms of action of these agents. In this regard, we 
would like to mention that studies using inhibitors have 
suggested that serine/threonine and tyrosine protein ki- 
nases participate in the increase in c-fos expression in 
hepatocytes induced by PMA and angiotensin II but that 
some differences in the actions of these agents were 
observed [ 16]. 
In contrast to the remarkable ffect of angiotensin II 
and PMA on c-fos transcription, there was essentially no 
effect of these agents on the rate of GAPDH gene tran- 
scription (Fig. 1). These data clearly indicate that the 
effects of the vasopressor peptide and the tumor promoter 
were not general on gene transcription but relatively spe- 
Buf fer  • Oo  • 
P M A • o 
i iiiiii/~' ~iii ~' i~? ~i!iiii ~ A n g IT .... :, 
Cyclo • 
o ~o' 2o' 40' 6o' 9o' 
(D 
0 
> 
.g ~oo 
,,I,-- 
¢-- 80 
< 
Z 4O n~ 
E 
~ 20 ol 
o 
c= 
o 
E 
0 
t -  
~ ~ RNA Extraction 
t I I I I I I I 
-15 0 30 
0 10 20 40 60 
T ime (min)  
90 
L • • • 
C. Gonzflez-Espinosa, J.A. Garcfa-Sfinz / Biochimica et Biophysica Acta 1310 (1996) 217-222 219 
I I I I I 
10 20 40 60 90 
Time (min) 
Fig. 2. Analysis of c-los mRNA stability. Cells were preincubated for15 
min with buffer, at this point, buffer (O), 0.1 /zM angiotensin II (zx), 1 
/zM PMA (O) or 10 /zg/ml cycloheximide (• )  were added. Incubation 
was continued for 30 min and then 5 /xg/ml actinomycin D was added. 
Incubation further continued for the times indicated and total RNA was 
isolated, spotted onto nylon membranes and hybridized with Nick-trans- 
lated c-fos probe. Plotted are the means of five independent experiments 
(S.E.M. are within the symbols), data are presented as percentage of 
initial values (time 0). Inset shows a representative experiment. 
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of c-fos mRNA induced by angiotensin II and PMA was 
greatly reduced by preincubation with actinomycin D [15]; 
however, basal c-fos expression was also reduced and an 
effect of both angiotensin II and PMA even in the presence 
of this transcription i hibitor was evident [15]. These data 
suggested that PMA and angiotensin II exerted effect(s) at 
post-transcriptional level(s). 
In order to test this hypothesis we measured c-fos 
mRNA half-life. Two types of experiments were per- 
formed. In one set of experiments cells were incubated in 
the absence of any agent or in the presence of angiotensin 
II (100 nM), PMA ( 1 /zM) or cycloheximide (10 /zg/ml) 
during 30 rain; this time was selected to obtain maximal 
c-fos mRNA accumulation [15]. After this time, actino- 
mycin D (5 /zg/ml) was added to block transcription and 
total RNA was isolated at the times indicated (Fig. 2). As 
can be observed, in cells incubated with buffer alone, the 
level of expression of c-fos mRNA rapidly decreased. The 
rate at which the amount of c-fos mRNA diminished was 
slowed down by treatment with PMA or angiotensin II 
(Fig. 2). Interestingly, the effect of angiotensin II on 
mRNA stability was clearly more marked than that of 
PMA, in contrast with the effects on transcription (Fig. 2). 
Cycloheximide markedly increased c-fi~s mRNA stability 
(Fig. 2). The half-life values obtained from these experi- 
ments are presented in Table 1. These results clearly 
indicate that angiotensin II and PMA are able to modulate 
post-transcriptionally thelevel of expression of this proto- 
oncogene. 
In another set of experiments, the cells were preincu- 
bated with actinomycin D for 15 min before the addition 
of any agent. After this preincubation, hepatocytes were 
incubated for 30 min (maximal c-fos accumulation) in the 
absence or presence of angiotensin II, PMA or cyclohex- 
imide and the incubation continued for different times 
(Fig. 3). The amount of c-fos mRNA was much lower than 
that in the previous et of experiments (= 50%). Neverthe- 
less, as it can be observed, the data obtained were very 
similar to those in Fig. 2, i.e., in cells incubated with 
buffer alone, a very rapid decrease in the signal was 
observed, and such decrease was slowed down by PMA, 
Table l 
Half-life values of c-fos mRNA 
Agent added Condition 
Addition of actinomycin D After 
30 min of incubation with the 
agents (Fig. 2) 
Half-life (min) 
Pre-incubation with 
actinomycin D 
(Fig. 3) 
Buffer 18+5 14_+5 
Angiotensin II 71 4- 7 65 + 6 
PMA 38 4- 4 40 + 5 
Cycloheximide >> 90 >> 90 
Data were obtained from the regression analysis of values in Figs. 2 and 
3. Data are the means + S.E.M. of 5 experiments. 
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Fig. 3. Analysis of c-fos mRNA stability. Cells were preincubated with 5 
/xg/ml actinomycin D, at this point agents were added (symbols as in 
Fig. 2). Incubation was continued for 30 min and at the times indicated 
total RNA was isolated as in Fig. 2. Plotted are the means of five 
independent experiments (S.E.M. are within the symbols), data are pre- 
sented as percentage of initial values (time 0). Inset shows a representa- 
tive experiment. 
angiotensin II and cyctoheximide. Again, angiotensin II 
was more effective than PMA and cycloheximide nor- 
mously stabilized mRNA (Fig. 3). The half-life values 
obtained from these experiments are presented in Table 1. 
It can be observed that the values are remarkably similar in 
both sets of experiments. The data indicate that angiotensin 
and PMA modulate the level of c-fos mRNA at a post- 
transcriptional level and that such an effect is also indepen- 
dent of de novo transcription. In other words, that such 
modifications of mRNA half-life occurred through molecu- 
lar entities already present in the cell repertoire. 
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The ability of cycloheximide to induce proto-oncogene 
expression in liver has been extensively documented both 
in vivo and in vitro [15,16,21,22]. It is well known that 
agents that inhibit protein synthesis (such as cyclohex- 
imide) promote c-fos mRNA accumulation i different cell 
types [23]. Indeed the mRNA for these genes is 'superin- 
duced' in the presence of cycloheximide and anisomycin, 
which suggests that short-lived protein(s), continuously 
synthesized de novo, inhibit mRNA turnover [24]. 
The effects of PMA and angiotensin II on proto-onco- 
gene mRNA stabilization in liver cells have not been 
described before. The angiotensin II receptor that mediates 
this effect in liver cells is of the AT 1 subtype [13,15]. This 
receptor subtype has already been cloned and belongs to 
the seven transmembrane domains family of receptors, 
coupled to G proteins [25,26]. Activation of these receptors 
in liver cells stimulate the phosphoinosit ide 
turnover/calcium obilization signal transduction process 
[ 13,14]. Surprisingly, activation of other receptors coupled 
to the same signal transduction pathway in these cells, 
such as the a,3-adrenoceptors  the V 1 vasopressin recep- 
tors, does not increase c-fos expression as the stimulation 
of the AT1 receptor does [15]; this suggests that additional 
signalling pathways could be involved. In fact, it has been 
shown that angiotensin II is able to induce tyrosine phos- 
phorylation of different proteins in vascular smooth muscle 
cells [27], GN4 liver epithelial cells [28] and neonatal 
fibroblast [29]. It has also been recently reported that 
activation of ATj receptors induced tyrosine phosphoryla- 
tion of phospholipase C y in vascular smooth muscle cells 
and that this action is, at least partially, responsible for the 
increase in IP 3 production induced by angiotensin II in 
these cells [30]. This effect is similar to that induced by 
EGF on phospholipase C y [31]. Additional similarities in 
the effects of stimulation of AT 1 angiotensin II receptors 
as compared to those of growth factor receptors with 
tyrosine kinase activity exist: angiotensin II, like PDGF, is 
able to stabilize JE (monocyte chemoattractant) mRNA in 
cultures of vascular smooth muscle cells [32]. In addition, 
very recently it was shown that angiotensin I1 AT1 recep- 
tors directly stimulate the Jak/STAT pathway [33]. 
The ability of PMA to stabilize mRNA has been re- 
ported in human HL-60 leukemic ells. In these cells, the 
presence of phorbol ester-regulated translational inhibitors 
has been demonstrated [34]. It is possible that PMA may 
induce c-fos mRNA stabilization through a similar mecha- 
nism; however, the existence of such translational in- 
hibitors in liver cells remains to be experimentally shown. 
In liver cells there is evidence of post-transcriptional 
control of gene expression by hormones. Glucagon induces 
PEPCK gene expression and such induction is correlated 
with the binding of a cytosolic protein to the 3' end of the 
PEPCK mRNA which modulates its half-life [35]. In addi- 
tion, it has been shown that insulin and glucagon antago- 
nize each other at the levels of both PEPCK gene expres- 
sion and binding of cytosol proteins to PEPKC mRNA 
[36]. Insulin modulates the expression of several proto- 
oncogenes such as c-fos and c-myc in H4 hepatoma cells 
[37,38]. Interestingly, the effect of insulin on c-fos expres- 
sion seems to be partially mediated through activation of 
protein kinase C. 
In summary, our present findings clearly indicate that 
angiotensin II and PMA modulate c-fos expression by 
increasing both gene transcription and mRNA stability, 
The effects of angiotensin II are particularly interesting 
since similarities in the action of this mediator and growth 
factors are evidenced. 
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